Enliven
ELVN

Enliven (ELVN) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
MizuhoMaintainedOutperform$73.00 from $62.00Aug 18, 2026
William BlairInitiated CoverageOutperformAug 18, 2026
BarclaysInitiated CoverageOverweight$78.00Aug 18, 2026
Goldman SachsMaintainedBuy$80.00 from $67.00Aug 6, 2026
StifelMaintainedBuy$82.00 from $80.00Aug 6, 2026
GuggenheimMaintainedBuy$78.00 from $80.00Aug 6, 2026
Goldman SachsMaintainedBuy$67.00 from $59.00Jul 21, 2026
HC Wainwright & Co.MaintainedBuy$64.00 from $56.00Jul 9, 2026
StifelMaintainedBuy$80.00 from $60.00Jul 1, 2026
Jones TradingMaintainedBuy$70.00 from $45.00Jun 29, 2026
StifelInitiated CoverageBuy$60.00Jun 9, 2026
MizuhoMaintainedOutperform$62.00 from $45.00Jun 2, 2026
Goldman SachsMaintainedBuy$59.00 from $41.00May 8, 2026
HC Wainwright & Co.MaintainedBuy$56.00 from $48.00Mar 26, 2026
MizuhoMaintainedOutperform$45.00 from $41.00Mar 25, 2026
HC Wainwright & Co.MaintainedBuy$48.00 from $40.00Jul 2, 2025
BairdMaintainedOutperform$52.00 from $40.00Jun 16, 2025
Goldman SachsInitiated CoverageBuy$37.00Jun 16, 2025
Jones TradingMaintainedBuy$27.00 from $36.00May 16, 2025
HC Wainwright & Co.MaintainedBuy$40.00 from $39.00May 15, 2025

Frequently asked questions

  • What is the latest analyst rating on ELVN?

    On Aug 18, 2026, Mizuho maintained Enliven at Outperform with a price target of $73.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.